WHO ADVISER CONCEALS A DONATION OF MILLIONS FROM A PHARMACEUTICAL COMPANY
Thursday, 17 December 2009 11:33
WHO ADVISER CONCEALS A DONATION OF MILLIONS FROM A PHARMACEUTICAL COMPANY
Written by Louise Voller & Kristian Villesen for the Danish daily newspaper, “Information”
10.12. 2009
A Finnish member of the WHO board, an advisor on vaccines, has received 46 million crowns (6 million euros) for his research centre from the vaccine manufactures, GlaxoSmithKline. WHO promises transparency, but this conflict of interests is not available for the public to see at WHO’s homepage.
Another ‘WHO’ vaccine advisor is withholding information concerning financial support from the pharmaceutical industry.
Professor Juhani Eskola is the director of the Finnish research vaccine programme (THL) and a new member of the WHO group, ‘Strategic Advisory Group of Experts’ (SAGE), which gives advice to the WHO Director-General, Margaret Chan. ‘SAGE’ also recommend which vaccines - and how many - member countries should purchase for the pandemic.
According to documents acquired through the Danish ‘Freedom of Information Act,’ Professor Juhani Eskola’s Finnish institute, THL, received almost 6.3 million Euro from GlaxoSmithKline (GSK) for research on vaccines during 2009.
This amount of money qualifies GlaxoSmithKline as THL’s main source of income.
HERE to read the complete article
